Dr Ilisa B. G. Bernstein joins Ethics Talk to discuss her article, coauthored with Karin L. Bolte: “Is My Patient Taking an Unsafe Dietary Supplement?”
Elizabeth Richardson joins Ethics Talk to discuss her article, coauthored Farzana Akkas and Dr Amy B. Cadwallader: “What Should Dietary Supplement Oversight Look Like in the US?”
Dr Alexander Ding joins Ethics Talk to discuss his article, coauthored with Dr Amy B. Cadwallader and other members of the AMA Council on Science and Public Health: “Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention?”
Dr Ala Shaikhkhalil joins Ethics Talk to discuss her article, coauthored with Drs Ethan A. Mezoff and Hannah Hays: “Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D?”
Sarosh Nagar joins Ethics Talk to discuss his article, coauthored with Drs Leah Z. Rand and Aaron S. Kesselheim: “What Should US Policymakers Learn From International Drug Pricing Transparency Strategies?”
When a child or family begins to stand out because of patterns in history or physical findings, physicians must determine whether to take a closer look at the situation.
Clinicians must avoid violating professional ethical principles and patients’ legal rights and they may not ever discriminate. So, what does that mean in practice?
AMA J Ethics. 2016;18(3):229-236. doi:
10.1001/journalofethics.2016.18.3.ecas4-1603.